The S & P 500 is down 18.8% from its highs. Most experienced technical analysts are suggesting there is likely to be a further decline at least 15%. This view is because the market professionals cannot see anything but an earnings compression in the US on the back of falling demand caused by rising prices (inflation) and interest rates.
Now because the demand for consumer staples does not decline on the back of a recessionary context, contrary to the broader market consumer staples grow in value during the period of a general earnings compression.
Sorry thats the S&P declined 5% over a 3 year period for part of that time the decline was much larger.
Now A2 is a classic consumer staple, and it has no debt and a bucket of cash, and is trading at multiples the lowest for many many years.
Where do you think the big boys will rotate to? Blackrock is the first of many to come in the next few months.
- Forums
- ASX - By Stock
- A2M
- Consumer Staples are the place to be in a period of earnings compression
A2M
the a2 milk company limited
Add to My Watchlist
1.67%
!
$7.93

Consumer Staples are the place to be in a period of earnings compression
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.93 |
Change
0.130(1.67%) |
Mkt cap ! $5.741B |
Open | High | Low | Value | Volume |
$7.87 | $7.99 | $7.71 | $17.74M | 2.261M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 111 | $7.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.96 | 3799 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 7.710 |
4 | 5739 | 7.700 |
1 | 64 | 7.680 |
3 | 2750 | 7.670 |
1 | 500 | 7.660 |
Price($) | Vol. | No. |
---|---|---|
7.960 | 565 | 1 |
7.990 | 8000 | 1 |
8.000 | 6318 | 7 |
8.010 | 6039 | 2 |
8.020 | 3294 | 2 |
Last trade - 16.13pm 27/06/2025 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online